0001610618-21-000020.txt : 20210319 0001610618-21-000020.hdr.sgml : 20210319 20210319210238 ACCESSION NUMBER: 0001610618-21-000020 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210317 FILED AS OF DATE: 20210319 DATE AS OF CHANGE: 20210319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sandison Taylor CENTRAL INDEX KEY: 0001702287 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36912 FILM NUMBER: 21759647 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cidara Therapeutics, Inc. CENTRAL INDEX KEY: 0001610618 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 461537286 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-752-6170 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: K2 THERAPEUTICS, INC. DATE OF NAME CHANGE: 20140611 4 1 wf-form4_161620214078608.xml FORM 4 X0306 4 2021-03-17 0 0001610618 Cidara Therapeutics, Inc. CDTX 0001702287 Sandison Taylor C/O CIDARA THERAPEUTICS, INC. 6310 NANCY RIDGE DR, STE 101 SAN DIEGO CA 92121 0 1 0 0 Chief Medical Officer Common Stock 81331 D Employee Stock Option (right to buy) 2.55 2021-03-17 4 A 0 145000 0 A 2031-03-16 Common Stock 145000.0 145000 D Includes 8,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 20, 2020 and November 20, 2020. The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 17, 2021. /s/ Taylor Sandison 2021-03-19